Search
Showing results for "1"
 
    News & Events
COVID Update August 2022We have been advised by the Department of Infectious Diseases at Perth Children's Hospital and the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia that COVID-19 vaccinations are now available for young children aged 6 months to 4 years with type 1 diabetes.
 
    News & Events
Kids rock out at diabetes campKids living with Type 1 Diabetes were literally blown away when the Westpac Lifesaver Rescue Helicopter dropped in at the Diabetes WA and PMH kids' camp.
 
    We know many families have questions about the risk of COVID-19 to children with type 1 diabetes. To address these questions, Perth Children’s Hospital’s Diabetes Clinic has provided information and resources to help you navigate this tricky period.
Research
The CoolCot trial: active methods of therapeutic hypothermia for newborns with hypoxic ischaemic encephalopathy during neonatal transport: a study protocol for a randomised controlled trialImpaired oxygen delivery or blood flow to the brain around the time of birth can cause injury. Hypoxic ischaemic encephalopathy is a leading cause of death and disability in term and near-term infants.
Research
Study protocol for Healthy Conversations @ Playgroup: a multi-site cluster randomized controlled trial of an intervention to promote healthy lifestyle behaviours in young children attending community playgroupsEarly childhood is a critical window for preventing obesity and chronic disease. Yet, 1 in 4 Australian children aged 5 years and under are affected by overweight or obesity; and significant proportions of children under 5 years fail to meet guidelines for diet quality, physical activity (PA), screen time, and sleep.
Research
Exploring the synthetic potential of a marine transaminase including discrimination at a remote stereocentreThe marine transaminase, P-ω-TA, can be employed for the transamination from 1-aminotetralins and 1-aminoindanes with differentiation of stereochemistry at both the site of reaction and at a remote stereocentre resulting in formation of ketone products with up to 93% ee. While 4-substituents are tolerated on the tetralin core, the presence of 3- or 8-substituents is not tolerated by the transaminase.
 
    News & Events
Global presenceOver the past few months, our researchers have zig-zagged the globe to share their type 1 diabetes research at major scientific meetings and conferences.
Research
Forecasting COVID-19 activity in Australia to support pandemic response: May to October 2020As of January 2021, Australia had effectively controlled local transmission of COVID-19 despite a steady influx of imported cases and several local, but contained, outbreaks in 2020. Throughout 2020, state and territory public health responses were informed by weekly situational reports that included an ensemble forecast of daily COVID-19 cases for each jurisdiction.
Research
Advocating for Implementation of the Global Action Plan on Physical Activity: Challenges and Support RequirementsThere is limited understanding of the challenges experienced and supports required to aid effective advocacy of the Global Action Plan on Physical Activity (GAPPA). The purpose of this study was to assess the challenges experienced and supports needed to advocate for the GAPPA across countries of different income levels.
Research
Continuous electroencephalography in the intensive care unit: A critical review and position statement from an Australian and New Zealand perspectiveThis article aims to critically review the literature on continuous electroencephalography (cEEG) monitoring in the intensive care unit (ICU) from an Australian and New Zealand perspective and provide recommendations for clinicians. Design and review methods: A taskforce of adult and paediatric neurologists, selected by the Epilepsy Society of Australia, reviewed the literature on cEEG for seizure detection in critically ill neonates, children, and adults in the ICU.